Busca avançada
Ano de início
Entree


Crosstalk between incretin hormones, Th17 and Treg cells in inflammatory diseases

Texto completo
Autor(es):
da Silva, Eloisa Martins ; Yariwake, Victor Yuji ; Alves, Renan Willian ; de Araujo, Daniele Ribeiro ; Andrade-Oliveira, Vinicius
Número total de Autores: 5
Tipo de documento: Artigo Científico
Fonte: Peptides; v. 155, p. 13-pg., 2022-07-04.
Resumo

Intestinal epithelial cells constantly crosstalk with the gut microbiota and immune cells of the gut lamina propria. Enteroendocrine cells, secrete hormones, such as incretin hormones, which participate in host physiological events, such as stimulating insulin secretion, satiety, and glucose homeostasis. Interestingly, evidence suggests that the incretin pathway may influence immune cell activation. Consequently, drugs targeting the incretin hormone signaling pathway may ameliorate inflammatory diseases such as inflammatory bowel diseases, cancer, and autoimmune diseases. In this review, we discuss how these hormones may modulate two subsets of CD4 + T cells, the regulatory T cells (Treg)/Th17 axis important for gut homeostasis: thus, preventing the development and progression of inflammatory diseases. We also summarize the main experimental and clinical findings using drugs targeting the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide (GLP-1) signaling pathways and their great impact on conditions in which the Treg/Th17 axis is disturbed such as inflammatory diseases and cancer. Understanding the role of incretin stimulation in immune cell activation and function, might contribute to new therapeutic designs for the treatment of inflammatory diseases, autoimmunity, and tumors. (AU)

Processo FAPESP: 19/14755-0 - Modulação da microbiota intestinal e do sistema imune pelas células epiteliais intestinais: da homeostase tecidual às doenças
Beneficiário:Vinicius de Andrade Oliveira
Modalidade de apoio: Auxílio à Pesquisa - Jovens Pesquisadores
Processo FAPESP: 20/14388-4 - Sinalização de incretinas na progressão tumoral em modelo experimental de Câncer Colorretal associado à Colite
Beneficiário:Eloisa Martins da Silva
Modalidade de apoio: Bolsas no Brasil - Doutorado Direto